全文获取类型
收费全文 | 1343篇 |
免费 | 0篇 |
专业分类
化学工业 | 3篇 |
能源动力 | 1篇 |
轻工业 | 2篇 |
无线电 | 6篇 |
一般工业技术 | 4篇 |
冶金工业 | 1324篇 |
自动化技术 | 3篇 |
出版年
2024年 | 1篇 |
2016年 | 1篇 |
2015年 | 1篇 |
2011年 | 1篇 |
2009年 | 1篇 |
2008年 | 1篇 |
2006年 | 3篇 |
2005年 | 1篇 |
2004年 | 1篇 |
2003年 | 4篇 |
1999年 | 35篇 |
1998年 | 351篇 |
1997年 | 216篇 |
1996年 | 136篇 |
1995年 | 68篇 |
1994年 | 81篇 |
1993年 | 81篇 |
1992年 | 10篇 |
1991年 | 28篇 |
1990年 | 25篇 |
1989年 | 23篇 |
1988年 | 37篇 |
1987年 | 25篇 |
1986年 | 12篇 |
1985年 | 19篇 |
1983年 | 4篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1978年 | 3篇 |
1977年 | 54篇 |
1976年 | 90篇 |
1975年 | 3篇 |
1965年 | 1篇 |
1955年 | 2篇 |
排序方式: 共有1343条查询结果,搜索用时 15 毫秒
81.
82.
83.
GW Bryant 《Canadian Metallurgical Quarterly》1990,41(2):1243-1246
84.
85.
JD Spencer N Latt PJ Beeby E Collins JB Saunders GW McCaughan YE Cossart 《Canadian Metallurgical Quarterly》1997,4(6):395-409
The acute effects of a newly synthesized thromboxane dual blocker (KDI-792), a combined thromboxane synthase inhibitor and receptor antagonist, on lower limb circulation were examined using two-dimensional color and pulse Doppler ultrasonography and laser Doppler flowmetry. A randomized single-masked, placebo-controlled trial was performed on 36 type 2 diabetic patients with minimally impaired baseline flow. The anatomical cross-sectional area (CSA), maximum flow velocity (MFV) and flow volume index (FVI) in the right dorsal pedis artery (DPA) and right femoral artery (FA) were determined by Doppler ultrasonography before and 45 and 90 minutes after the administration of either 100 or 200 mg of KDI-792 to the dose groups or placebo to the control group. Periflux blood flow (PBF) in the right foot was determined simultaneously by laser Doppler flowmetry. Both CSA and MFV in the dose groups were significantly increased in both the FA and DPA. FVI was markedly increased from 21.4 +/- 3.7 to 68.3 +/- 26.8 in the DPA (M +/- SD, P < 0.01) and from 365.4 +/- 35.3 to 771.7 +/- 75.7 in the FA (P < 0.01) in the 200 mg dose group. In the 100 mg dose group, FVI was markedly increased from 20.0 +/- 8.7 to 68.3 +/- 26.8 (P < 0.01) in the DPA and from 372.5 +/- 130.0 to 677.5 +/- 187.8 (P < 0.01) in the FA. PBF was also increased in both dose groups (from 4.15 +/- 1.4 to 7.0 +/- 4.0 ml/min/100 g tissue in the 200 mg dose group, P < 0.01), whereas there were no significant changes in either measurement in the control group. There were no significant changes in pulse rate or blood pressure after administration in either the dosage group or the placebo group. These and previous findings indicate that a single administration of KDI-792 markedly increases lower limb blood flow and might have a more potent vasodilating effect than that of prostaglandin I2 derivatives. 相似文献
86.
Classroom peer acceptance, friendship, and victimization: distinct relational systems that contribute uniquely to children's school adjustment? 总被引:1,自引:0,他引:1
The proposition that relationships make differential (i.e., unique, redundant, contingent) contributions to adjustment was examined by investigating the linkages between children's participation in different types of peer relationships (i.e., friendship, peer acceptance, peer victimization) and their adjustment to school. Relationship measures were gathered for 5- to 6-year-old children (105 males, 95 females) twice during kindergarten (i.e., fall and spring) and were correlated with adjustment indicators at each time of assessment and used to predict changes in school adjustment over time. Examination of the relative associations between the relationship measures and children's adjustment revealed evidence of both unshared (i.e., unique) and shared (i.e., redundant) linkages, depending on the form of adjustment examined. These findings suggest that adjustment may be influenced by the diverse experiences (i.e., provisions) that children encounter in different forms of relationship, and that certain types of relationships may have greater or lesser adaptive significance depending on the adjustment outcome examined. 相似文献
87.
DC Thomas KC Butler LP Taylor P Le Blanc BP Griffith RL Kormos HS Borovetz P Litwak MV Kameneva S Choi GW Burgreen WR Wagner Z Wu JF Antaki 《Canadian Metallurgical Quarterly》1997,43(5):M564-M566
Nimbus and the University of Pittsburgh (UOP) have continued the development of a totally implanted axial flow blood pump under the National Institutes of Health (NIH) Innovative Ventricular Assist System (IVAS) program. This 62 cc device has an overall length of 84 mm and an outer diameter of 34.5 mm. The inner diameter of the blood pump is 12 mm. It is being designed to be a totally implanted permanent device. A key achievement during the past year was the completion of the Model 2 pump design. Ten of these pumps have been fabricated and are being used to conduct in vitro and in vivo experiments to evaluate the performance of different materials and hydraulic components. Efforts for optimizing the closed loop speed control have continued using mathematical modeling, computer simulations, and in vitro and in vivo testing. New hydraulic blade designs have been tested using computational fluid dynamics (CFD) and flow visualization. A second generation motor was designed with improved efficiency. To support the new motor, a new motor controller fabricated as a surface mount PC board has been completed. The program is now operating under a formal QA system. 相似文献
88.
JS de Oliveira Mde L Chauffaille GW Colleoni VM Morelli OM Hauache VN Alberti J Kerbauy 《Canadian Metallurgical Quarterly》1998,116(2):1689-1691
The authors report the case of a chronic myeloid leukemia (CML) patient submitted to allogenic bone marrow transplantation, who had probably never entered complete remission. The disease was reactivated as a granulocytic sarcoma, next to a platinum plate installed to correct a tibia fracture 11 years earlier. Its final event was a myeloid Ph1 + blastic crisis that was unsuccessfully treated with high doses of sc interferon and citarabine. 相似文献
89.
CR Zimmermann SM Johnson GW Martens AG White BL Zimmer D Pappagianis 《Canadian Metallurgical Quarterly》1998,66(5):2342-2345
The formaldehyde-killed, whole-spherule vaccine, which is protective against lethal challenge of laboratory animals with Coccidioides immitis, was fractionated. It yielded a soluble, multicomponent, subcellular fraction termed the 27K vaccine. This vaccine, when it was accompanied by adjuvant, protected mice against lethal intranasal and intravenous challenge with C. immitis. 相似文献
90.
GL Kay GW Sun A Aoki CA Prejean 《Canadian Metallurgical Quarterly》1995,60(6):1640-50; discussion 1651
BACKGROUND: Preoperative ejection fraction (EF) has been shown to adversely affect postoperative hospital mortality and morbidity for patients undergoing isolated coronary artery bypass grafting. METHODS: To investigate influence of EF on isolated coronary artery bypass grafting outcomes (overall hospital mortality, hospital cardiac mortality, hospital morbidity, and hospital costs), data were reviewed from 1,354 consecutive patients who underwent isolated coronary artery bypass grafting between January 1, 1990, and April 30, 1992, at a single nonprofit hospital. Overall hospital mortality was 4.06% (cardiac, 2.36%). Hospital morbidity was 14.25% (including mortality). Hospital costs (not charges) averaged $16,673 per patient. To explore the impact of preoperative EF, EF was stratified into regular intervals. Each interval was then compared with regard to hospital mortality, morbidity, and average costs. A new statistical tool, discharge analysis, was developed to analyze the cost data. This was necessary because previous efforts at cost analysis have used tools inappropriate for real world cost data. RESULTS: The statistical analysis showed that patients with EF of 0.40 or greater had the best outcomes (lowest mortality, morbidity, and cost). Once the EF is 0.40 or greater the EF does not carry further predictive value. At EF less than 0.40, patients with EF less than 0.30 have a poorer outcome than patients with EF of 0.30 to 0.39. CONCLUSIONS: (1) Ejection fraction is a valid predictor of mortality, morbidity and resource utilization based on statistical analysis. (2) Patients can be broadly grouped as having EF greater than 0.40, less than 0.30, or from 0.30 to 0.39 with regard to clinical and cost outcomes. (3) Postoperative length of stay is not predicted by risk-adjusted EF. (4) A new tool, discharge analysis, is presented to facilitate cost analysis. 相似文献